The Brand Name CHEXID Has Generic Salt :: Lansoprazole 

CHEXID  Is From Company Aristo Priced :: Rs. 38

CHEXID have Lansoprazole is comes under Sub class GERD, of  Main Class Gastrointestinal System

Main Medicine Class:: Gastrointestinal System  Sub Medicine Class :: GERD, 

 Salt Name :  OR Generic Name Form Price : MRP /Probable Packing
Lansoprazole  CAP  Rs. 38  10
Brand Name Company / Manufacturers Strength Unit Price / 10
 CHEXID  Aristo  30MG  10 Rs. 38

Company  Brand Name  Salt Combination Main Medical Class Sub Medical Class
 From Aristo :: CHEXID  Lansoprazole  Gastrointestinal System GERD,

Indications for Drugs ::

Peptic ulcer, H.pylori infection, Gastro-oesophageal reflux disease, Hypersecretory conditions, Acid-related dyspepsia, NSAID-induced ulcers, Erosive oesophagitis

Drug Dose ::

Adult: PO Peptic ulcer 30 mg once in the morning for 4 wk (duodenal ulcer) or 8 wk (gastric ulcer). Hypersecretory conditions Initial: 60 mg/day. Daily doses >120 mg should be given in 2 divided doses. Acid-related dyspepsia 15-30 mg once in the morning for 2-4 wk. Gastro-oesophageal reflux disease 30 mg once in the morning for 4-8 wk. Maintenance: 15-30 once daily. Prevention and treatment of NSAID-related ulcers 15-30 mg/day for 4-8 wk. Child: 1-11 yr <30 kg: 15 mg once daily in the morning for up to 12 wk; >30 kg: 30 mg once daily in the morning for up to 12 wk. May increase doses up to 30 mg bid if patient is still symptomatic after 2 or more wk of treatment. 12-17 yr 30 mg once daily for up to 8 wk. H.pylori infection 30 mg twice daily, usually w/ clarithromycin and amoxicillin or metronidazole. IV Erosive oesophagitis 30 mg/day for up to 7 days.

Contraindication ::

Hypersensitivity.

Drug Precautions ::

Hepatic impairment. Gastric malignancy should be ruled out. Pregnancy and lactation.

Drug Side Effects ::

Diarrhoea, abdominal pain, nausea, constipation, headache, dizziness, eosinophilia, myalgia, glossitis, stomatitis, rash.

Pregnancy category ::
Pregnancy category

2

Drug Mode of Action ::  

Lansoprazole is a substituted benzimidazole, and is also known as PPI due to its property to block the final step of acid secretion by inhibiting H+/K+ ATPase enzyme system in gastric parietal cell. Both basal and stimulated acid are inhibited.

Drug Interactions ::

Increased risk of hypomagnesaemia w/ diuretics and digoxin. May decrease plasma concentration of erlotinib, dasatinib and lapatinib. May decrease the bioavailability of itraconazole and ketoconazole. May increase plasma concentration of cilostazol and methotrexate. Reduced bioavailability w/ antacids and sucralfate. Potentially Fatal: May decrease serum levels and pharmacological effects of rilpivirine and atazanavir.

 

Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.

DOWNLOAD OUR ANDROID APP

One of the 1st in India.High Quality Generic Medicine Portal Android Application for Online Oreder & Information.

For More Join Our Membership and Get Additional 25% off on Meds, also get MLM Benefits to get a permanent earning source.

Join Membership How to Search Medicine
Android App

We would like to keep you updated with special notifications.